These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 1628708

  • 1. Biological activities of tetrapeptide AcSDKP on hemopoietic cell binding to the stromal cell in vitro.
    Aizawa S, Toyama K, Mori KJ, Frindel E.
    Exp Hematol; 1992 Aug; 20(7):896-9. PubMed ID: 1628708
    [Abstract] [Full Text] [Related]

  • 2. Activity of acetyl-n-ser-asp-lys-pro (AcSDKP) on hematopoietic progenitor cells in short-term and long-term murine bone marrow cultures.
    Jackson JD, Yan Y, Ewel C, Talmadge JE.
    Exp Hematol; 1996 Feb; 24(3):475-81. PubMed ID: 8599978
    [Abstract] [Full Text] [Related]

  • 3. Reversible inhibitory effects and absence of toxicity of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in human long-term bone marrow culture.
    Bonnet D, Lemoine FM, Khoury E, Pradelles P, Najman A, Guigon M.
    Exp Hematol; 1992 Nov; 20(10):1165-9. PubMed ID: 1385195
    [Abstract] [Full Text] [Related]

  • 4. Enhancement of the adherence of hematopoietic stem cells to mouse bone marrow-derived stromal cell line MS-1-T by a tetrapeptide acetyl-N-Ser-Asp-Lys-Pro.
    Lenfant M, Itoh K, Sakoda H, Sotty D, Sasaki NA, Wdzieczak-Bakala J, Mori KJ.
    Exp Hematol; 1989 Sep; 17(8):898-902. PubMed ID: 2767182
    [Abstract] [Full Text] [Related]

  • 5. The synthetic tetrapeptide AcSDKP protects cells that reconstitute long-term bone marrow stromal cultures from the effects of mafosfamide (Asta Z 7654).
    Genevay MC, Mormont C, Thomas F, Berthier R.
    Exp Hematol; 1996 Jan; 24(1):77-81. PubMed ID: 8536796
    [Abstract] [Full Text] [Related]

  • 6. Enhanced engraftment of intravenously transplanted hematopoietic stem cells into bone marrow of irradiated mice treated with AcSDKP.
    Suzuki A, Aizawa S, Araki S, Hoshi H, Nakano M, Kimura Y, Toyama K.
    Exp Hematol; 1998 Jan; 26(1):79-83. PubMed ID: 9430517
    [Abstract] [Full Text] [Related]

  • 7. Catabolism of the tetrapeptide N-Ac-Ser-Asp-Lys-Pro (AcSDKP), an inhibitor of hematopoietic stem cell (CFU-S) proliferation, following in vitro incubation with hematopoietic tissues from normal and leukemic mice.
    Wdzieczak-Bakala J, Grillon C, Robinson S, Riches A, Carde P, Lenfant M.
    Bull Cancer; 1993 May; 80(5):391-6. PubMed ID: 8173192
    [Abstract] [Full Text] [Related]

  • 8. The molecular specificity of action of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in the control of hematopoietic stem cell proliferation.
    Robinson S, Lenfant M, Wdzieczak-Bakala J, Riches A.
    Stem Cells; 1993 Sep; 11(5):422-7. PubMed ID: 8241953
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of hematopoiesis in long-term marrow cultures established on adherent layers from AcSDKP-treated dogs.
    Hong DS, Graham T, Ewel C, Storb R, Deeg HJ.
    Exp Hematol; 1995 Jul; 23(7):639-44. PubMed ID: 7601256
    [Abstract] [Full Text] [Related]

  • 10. Photoprotection of normal human hematopoietic progenitors by the tetrapeptide N-AcSDKP.
    Coutton C, Guigon M, Bohbot A, Ferrani K, Oberling F.
    Exp Hematol; 1994 Oct; 22(11):1076-80. PubMed ID: 7925774
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of human bone marrow progenitors by the synthetic tetrapeptide AcSDKP.
    Guigon M, Bonnet D, Lemoine F, Kobari L, Parmentier C, Mary JY, Najman A.
    Exp Hematol; 1990 Nov; 18(10):1112-5. PubMed ID: 2209766
    [Abstract] [Full Text] [Related]

  • 12. In vivo protective effects of tetrapeptide AcSDKP, with or without granulocyte colony-stimulation factor, on murine progenitor cells after sublethal irradiation.
    Watanabe T, Brown GS, Kelsey LS, Yan Y, Jackson JD, Ewel C, Kessinger A, Talmadge JE.
    Exp Hematol; 1996 May; 24(6):713-21. PubMed ID: 8635527
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and biological evaluation of analogues of the tetrapeptide N-Acetyl-Ser-Asp-Lys-Pro (AcSDKP), an inhibitor of primitive haematopoietic cell proliferation.
    Thierry J, Grillon C, Gaudron S, Potier P, Riches A, Wdzieczak-Bakala J.
    J Pept Sci; 2001 May; 7(5):284-93. PubMed ID: 11428549
    [Abstract] [Full Text] [Related]

  • 14. Goralatide (AcSDKP) selectively protects murine hematopoietic progenitors and stem cells against hyperthermic damage.
    Wierenga PK, Konings AW.
    Exp Hematol; 1996 Feb; 24(2):246-52. PubMed ID: 8641348
    [Abstract] [Full Text] [Related]

  • 15. [The hemoprotective effect of platelet factor 4 (PF4) and tetrapeptide AcSDKP].
    Han Z, Cai Y, Aidoudi S.
    Zhonghua Xue Ye Xue Za Zhi; 1999 Jan; 20(1):33-5. PubMed ID: 11498842
    [Abstract] [Full Text] [Related]

  • 16. Mechanisms mediating the inhibitory effect of all-trans retinoic acid on primitive hematopoietic stem cells in human long-term bone marrow culture.
    Sammons J, Ahmed N, Khokher MA, Hassan HT.
    Stem Cells; 2000 Jan; 18(3):214-9. PubMed ID: 10840075
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Further studies on the biological activities of the CFU-S inhibitory tetrapeptide AcSDKP. II. Unresponsiveness of isolated adult rat hepatocytes, 3T3, FDC-P2, and K562 cell lines to AcSDKP. Possible involvement of intermediary cell(s) in the mechanism of AcSDKP action.
    Lauret E, Dumenil D, Miyanomae T, Sainteny F.
    Exp Hematol; 1989 Dec; 17(11):1081-5. PubMed ID: 2583252
    [Abstract] [Full Text] [Related]

  • 20. Production and consumption of the tetrapeptide AcSDKP, a negative regulator of hematopoietic stem cells, by hematopoietic microenvironmental cells.
    Li J, Volkov L, Comte L, Herve P, Praloran V, Charbord P.
    Exp Hematol; 1997 Feb; 25(2):140-6. PubMed ID: 9015214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.